DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

UK approves gene therapy for sickle cell, thalassaemia

  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

London, November 16

Advertisement

Britain’s medicines regulator has authorised the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the UK.

In a statement on Thursday, the Medicines and Healthcare Regulatory Agency (MHRA) said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.

Advertisement

The agency approved the treatment for patients with sickle cell disease and thalassaemia who are over 12 years old. — AP

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts